InterCure Ltd. (INCR) has a negative trailing P/E of -3.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -27.02%.
Criteria proven by this page:
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2015 | -62.2 | 0.68 | 9.77 | 83.33 | - |
| 2016 | 617.8 | -5.61 | 6.81 | 0.00 | - |
| 2017 | -37.8 | 0.02 | 9.60 | 0.00 | - |
| 2018 | -20.6 | -0.21 | 13.44 | 0.00 | - |
| 2019 | -16.9 | 0.21 | 0.39 | 11.16 | - |
| 2020 | -2.8 | 0.00 | 0.39 | 1.63 | - |
| 2021 | 164.5 | -1.52 | 1.72 | 3.51 | - |
| 2022 | 11.7 | 0.02 | 1.05 | 1.35 | - |
| 2023 | -3.4 | 0.01 | 0.47 | 0.60 | - |
| 2024 | -4.1 | -0.92 | 0.69 | 1.15 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2015 | $-0.21 | $1.4M | $-1.88M | -134% |
| 2016 | $0.02 | $0.00 | $265.42K | - |
| 2017 | $-0.31 | $0.00 | $-5.26M | - |
| 2018 | $-0.62 | $0.00 | $-12.8M | - |
| 2019 | $-0.13 | $8.93M | $-5.89M | -66% |
| 2020 | $-1.42 | $65.04M | $-37.23M | -57.2% |
| 2021 | $0.10 | $219.68M | $4.69M | 2.1% |
| 2022 | $0.99 | $388.68M | $44.82M | 11.5% |
| 2023 | $-1.36 | $355.55M | $-61.96M | -17.4% |
| 2024 | $-1.42 | $238.85M | $-67.8M | -28.4% |
